PRINCETON JUNCTION, N.J., June 16 /PRNewswire/ -- R-Squared, an industry leader in compliance consulting and solutions, announced a multi-year partnership with the Medical Device Manufacturers Association (“MDMA”), a national trade association, based in Washington, D.C., representing more than 175 members, including manufacturers of medical devices and diagnostic products. Though the partnership, which was announced at the MDMA Annual Meeting, R-Squared will serve as MDMA’s preferred provider of Evidence-Based Compliance management systems, including programs that demonstrate best practices around financial relationships with, and tracking spending to, physicians and other referral sources.
“We could not be more excited about our partnership with MDMA,” said Michael Bell, Esq., Founder and Managing Member of R-Squared. “Our affordable next generation solutions are designed specifically to improve the performance and data analytics capabilities of device manufacturers, while at the same time preventing problems from occurring and evidencing compliance best practices.” At the Annual Meeting, Michael also participated on the panel of experts to discuss “Key Fraud and Abuse Issues in the Medical Technology Industry,” wherein Michael presented on trends in evidence-based compliance. “We are a small, service-oriented firm that marries substantive expertise with the latest in smart technologies. Our partnership with MDMA could not be a more perfect fit for us,” said Bell.
Through this relationship, MDMA members will have special access to R-Squared’s proprietary solutions, including Arrangements Keeper(SM), which was designed by leading health lawyers and compliance officers to merge internal controls and data to demonstrate compliant physician/manufacturer relationships, and SpendTracker(SM), which tracks, sorts, trends, and reports on aggregate spend. In addition, MDMA members will be entitled to discounts on consulting services and future software releases, including a to-be-named complete compliance system that is scheduled for release in the fourth quarter.
“Our partnership with R-Squared reflects MDMA’s commitment to its members to provide state-of-the-art solutions that will not only help our companies navigate the compliance complexities and avoid costly mishaps, but also provides them with key data and analytics for continuous business improvement,” said Mark B. Leahey, Esq., Executive Director of MDMA. “Michael Bell is a foremost expert in medical device compliance matters and a trusted advisor to MDMA and its members. We are pleased to be partnering with Michael and R-Squared.”
About R-Squared Services And Solutions, LLC. R-Squared -- short for “reimbursement and regulatory” -- is an independent software and consulting services firm that specializes in compliance and reimbursement strategies and solutions for health care and life sciences industries. To learn more about R- Squared please visit http://www.r2ss.com or call 609.378.5335.
About The Medical Device Manufacturers Association. MDMA is a national trade association based in Washington, D.C., representing innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace. Please visit http://www.medicaldevices.org to learn more about MDMA.
CONTACT: Michael Bell of R-Squared, +1-609-378-5335, mbell@r2ss.com
Web site: http://www.r2ss.com/
http://www.medicaldevices.org/
